Faculté de médecine, Sorbonne université, 91-105, boulevard de l'Hôpital, 75013 Paris, France; Department of Neurology and Stroke Center, centre hospitalier de Versailles, 177 rue de Versailles, 78150 Le Chesnay-Rocquencourt, France.
Interventional Neuroradiology Department, Fondation Rothschild, 25-29 rue Manin, 75019 Paris, France.
Rev Neurol (Paris). 2023 Mar;179(3):230-237. doi: 10.1016/j.neurol.2022.10.003. Epub 2023 Feb 15.
Endovascular treatment (EVT) is a well-established technic for acute ischemic stroke, but despite a high recanalization rate of near 80%, at 3 months roughly 50% of patients have a poor functional outcome with a modified Rankin score (mRS) ≥3. The aim of this study was to determine predictive factors of poor functional outcomes in patients with complete recanalization after EVT, defined as modified thrombolysis in cerebral infarction (mTICI) 3.
This retrospective analysis based on the prospective multicenter ETIS registry (endovascular treatment in ischemic stroke) in France included 795 patients from January 2015 and November 2019 with acute ischemic stroke due to anterior circulation occlusion and prestroke mRS 0-1, treated with EVT and who achieved complete recanalization. Univariate and multivariate logistic regression models were used to identify predictive factors of poor functional outcome.
365 patients (46%) showed a poor functional outcome (mRS>2). In backward-stepwise logistic regression analysis, poor functional outcome was independently associated with older age (OR per 10-year increase, 1.51; 95%CI, 1.30 to 1.75), higher admission NIHSS (OR per 1 point increase, 1.28; 95%CI, 1.21 to 1.34), absence of prior intravenous thrombolysis (OR, 0.59; 95%CI, 0.39 to 0.90), and an unfavorable 24-hour NIHSS change (24h-baseline) (OR, 0.82; 95%CI, 0.79 to 0.87). We calculated that patients whose 24h NIHSS decreased by less than 5 points are more at risk of a poor outcome, with a sensitivity and a specificity of 65.0%.
Despite complete reperfusion after EVT, half of patients had a poor clinical outcome. These patients, who were mainly older with a high initial NIHSS and an unfavorable post-EVT 24h NIHSS change, could represent a target population for early neurorepair and neurorestorative strategies.
血管内治疗(EVT)是急性缺血性脑卒中的一种成熟技术,但尽管再通率接近 80%,但在 3 个月时,近 50%的患者仍存在改良 Rankin 评分(mRS)≥3 的不良功能结局。本研究旨在确定 EVT 后完全再通患者(定义为改良脑梗死溶栓分级[mTICI]3)不良功能结局的预测因素。
这项基于法国多中心 ETIS 登记处(缺血性脑卒中血管内治疗)的回顾性分析纳入了 2015 年 1 月至 2019 年 11 月因前循环闭塞和术前 mRS 0-1 而接受 EVT 治疗并达到完全再通的 795 例急性缺血性脑卒中患者。使用单变量和多变量逻辑回归模型来识别不良功能结局的预测因素。
365 例(46%)患者存在不良功能结局(mRS>2)。在逐步后退逻辑回归分析中,年龄较大(每增加 10 岁,OR 为 1.51;95%CI,1.30 至 1.75)、较高的入院 NIHSS 评分(每增加 1 分,OR 为 1.28;95%CI,1.21 至 1.34)、无前期静脉溶栓(OR 为 0.59;95%CI,0.39 至 0.90)和 24 小时 NIHSS 变化不良(24h-基线)(OR 为 0.82;95%CI,0.79 至 0.87)与不良功能结局独立相关。我们计算得出,24 小时 NIHSS 降低<5 分的患者发生不良结局的风险更高,其敏感性和特异性分别为 65.0%。
尽管 EVT 后再通完全,但一半的患者仍存在不良临床结局。这些患者主要为年龄较大、初始 NIHSS 评分较高且 EVT 后 24 小时 NIHSS 变化不良的患者,可能是早期神经修复和神经修复策略的目标人群。